Key result
Adipsin deficiency fails to alter atherosclerosis development or metabolic parameters in hyperlipidemic mice.
Why the study?
The role of adipsin, an abundant adipokine and alternative complement activator, in the development of atherosclerosis remains unexplored.
Answers are grounded in this paper and cite their sources.
Adipsin unlikely to mediate obesity-related atherosclerosis risk; leaves open alternative adipokines or pathways for human studies.
BACKGROUND AND AIMS Obesity is a potent risk factor for atherosclerotic morbidity and mortality. Cytokines secreted from adipose tissue, namely adipokines, have been suggested to be actively involved in atherosclerosis. One of the most abundant adipokines, adipsin, is downregulated in obesity. It catalyzes the rate-limiting step of alternative complement activation, which is one of the three complement pathways potentially involved in inflammation in atherosclerosis. Interestingly, adipsin has been identified as a novel biomarker in human coronary artery disease. However, its role in the development of atherosclerosis remains unexplored. METHODS We crossed Adipsin-/- mice onto an Ldlr-/-background (DKO) and induced atherogenesis by high fat and high cholesterol feeding. Metabolic profiles were systemically characterized, and atherosclerotic plaques were measured at both aortic root and arch regions. Western blotting was conducted to assess adipsin level and complement activity. RESULTS The DKO mice exhibited similar sizes of atherosclerotic lesions as Ldlr-/-control mice at both the aortic root and arch regions. Accordingly, they displayed comparable metabolic parameters, including body weight, insulin sensitivity, and lipid profiles, along with compensated complement activity. CONCLUSIONS Adipsin deficiency does not impact the development of atherosclerosis in Ldlr-/-mice despite its crucial function in alternative complement activation. Therefore, it is unlikely to play an important role in mediating the risk of atherosclerotic complications in obesity.
No takes yet. Share an insight, caveat, or question.
Liu et al. (2020) studied Atherosclerosis. Adipsin deficiency vs. Ldlr-/- control mice was evaluated on Atherosclerotic lesion size at aortic root and arch regions. Adipsin deficiency did not impact the development of atherosclerosis or metabolic parameters in Ldlr-/- mice fed a high fat and high cholesterol diet.
Synapse has enriched 10 related papers. Consider them for comparative context: